Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation | 2013 | |||
Treatment options for C3 glomerulopathy | 2013 | |||
Eculizumab for the treatment of dense-deposit disease | New England Journal of Medicine |
| 2012 | |
Eculizumab in a patient with dense-deposit disease | New England Journal of Medicine |
| 2012 | |
A novel hybrid CFHR2/CFHR5 gene develops MPGN II and provides insights into disease mechanism and therapeutic implications | Immunobiology |
| 5 | 2012 |
Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
The complement cascade in renal pathology | Die Pathologie |
| 2024 | |
Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children | Pediatric Nephrology |
| 2024 | |
The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older | European Journal of Internal Medicine |
| 2024 | |
Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy | Kidney International Reports |
| 2024 | |
C3 Glomerulopathy: Novel Treatment Paradigms | Kidney International Reports |
| 2024 |